Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11311496 Transdermal delivery of large agents

Patent 11311496 was granted and assigned to Eirion Therapeutics on April, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11311496

Date of Patent

April 26, 2022

Patent Application Number

16462485

Date Filed

September 25, 2017

Patent Citations

‌

US Patent 10485855 Demonstrable efficacy across or within patient populations

‌

US Patent 10532019 Botulinum nanoemulsions

‌

US Patent 10576034 Botulinum nanoemulsions

‌

US Patent 10905637 Peptide nanoparticles and uses therefor

‌

US Patent 10758485 Amphiphilic entity nanoparticles

‌

US Patent 10016364 Compositions and methods for making and using nanoemulsions

‌

US Patent 10016451 Nucleic acid nanoparticles and uses therefor

‌

US Patent 10111939 Albumin-free botulinum toxin formulations

...

Patent Primary Examiner

‌

Nita M. Minnifield

Methods, compositions, and devices for enhancing transdermal delivery of large agents.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11311496 Transdermal delivery of large agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API